Education Hub
Insights & Research
Stay informed with the latest in precision medicine, regenerative therapies, and longevity science from our team.
Regenerative Orthopedics for the Hip: PRP, BMAC, and the New 15-Year Data Worth Knowing
A landmark 2026 study followed 434 hips for fifteen years and found that intraosseous bone marrow concentrate cut progression to total hip replacement from 40.1% to 16.1% — with a clear cell-dose response and zero adverse events. An evidence-graded read on biologics at the hip: when PRP and BMAC genuinely move the needle for hip arthritis, gluteal tendinopathy, and hamstring origin pain — and where the data still says no.
Regenerative Orthopedics for the Hand and Wrist: PRP Evidence Worth Knowing
For thumb CMC arthritis and refractory De Quervain’s, the data favors PRP over corticosteroid at 12 months — with a meaningfully better safety profile. But preparation quality matters: the latest placebo-RCT was negative, and the concentration used was a fraction of the positive trials. An honest, evidence-graded read on biologics at the hand and wrist.
Regenerative Orthopedics for the Elbow: PRP, BMAC, and the Evidence Worth Knowing
For chronic tennis elbow, the long-term data favors PRP over corticosteroid. For partial UCL tears in throwing athletes, the picture is more nuanced — encouraging case series, sobering MLB cohort data. Here’s an honest, evidence-graded read on where biologics genuinely help at the elbow.
Regenerative Orthopedics for the Shoulder: PRP, BMAC, and the Evidence Worth Knowing
Two papers should be on every physician’s desk before recommending biologics for the shoulder: Hernigou’s 10-year BMAC case-control series and Centeno’s 2024 randomized trial. Here’s an honest, evidence-graded read on PRP, BMAC, and where they fit alongside — or before — rotator cuff surgery.
Fractional Laser for Knee Cartilage: What the Evidence Shows
The Regenalase 1550 nm fiber laser is FDA-cleared (K233344) for soft-tissue including meniscus cartilage. Here’s an honest read on the device specs, the Scarpone case series, mini-pig preclinical data, and where this fits a physician’s evidence-graded treatment plan.
Fractional Laser for Spinal Discs: What the Evidence Actually Shows
Intradiscal Regenalase laser energy for degenerative disc disease is biologically intriguing — and the Baskov long-term series suggests a signal. Here’s what FDA clearance K233344 actually covers, what the data shows and doesn’t, and how we think about candidacy.
Stem Cell Banking with Forever Labs: A Physician’s Evidence-Graded Take
Banking your own mesenchymal stem cells today, in case the science matures, sounds intuitive. The decision is more nuanced. Here’s what the evidence supports, what it doesn’t, and what to ask before you write the check.
EV-Enhanced PRP: Promise, Limits, and Why the Distinction from “Exosomes” Matters
Autologous extracellular vesicles are being marketed as the next step beyond PRP. Here’s an evidence-graded read on what’s biologically real, what’s still preclinical, and what the FDA has actually said about unapproved exosome products.
MFAT for Knee and Joint Pain: What the Evidence Actually Shows
Micro-fragmented adipose tissue is one of the most discussed orthobiologics of the past five years. Here’s an honest read on what’s proven, what’s emerging, and where it might fit in your treatment plan.
How to Choose a Longevity Doctor: Red Flags, Green Flags, and What to Ask
Hundreds of “longevity clinics” have opened in the U.S. — from rigorously evidence-based practices to wellness spas charging $15,000 a year for unproven protocols. A board-certified physician’s insider guide to telling them apart.
Therapeutic Plasma Exchange: The Most Underrated Longevity Intervention?
FDA-approved since the 1970s. Stanford’s 2020 mouse-equivalent study extended median lifespan ~54%. Human trials show measurable cognitive and biological-age changes. Here’s what TPE really does — and what it doesn’t.
Environmental Toxins, Heavy Metals, and Microplastics: The Invisible Threat to Your Longevity
PFAS are found in 98% of Americans. Microplastics are now in human blood, placentas, and brains. Heavy metals raise cardiovascular risk in 33% of U.S. adults. Here’s what the evidence says — and what to do about it.
GLP-1 Medications and Longevity: Beyond Weight Loss
The SELECT trial showed a 20% drop in cardiovascular events. The FLOW trial cut kidney failure by 24%. Emerging data hints at Alzheimer’s and Parkinson’s benefit. Here’s what GLP-1 medications are really doing.
Metabolomics and Proteomics: The Blood Tests of the Future
A single blood draw can now measure 3,000 proteins and 1,000 metabolites — revealing organ-specific biological age, cancer risk, and metabolic dysfunction years before standard labs catch up. Here’s the evidence.
Digital Twins in Medicine: How AI Is Personalizing Your Health Plan
The FDA has cleared the first cardiovascular digital twin. Twin Health has reversed type 2 diabetes in 65% of users. Here’s what digital twin medicine really is — and what it isn’t.
Cell-Free DNA Cancer Screening: Early Detection Before Symptoms
70% of cancer deaths come from cancers with no standard screening test. The PATHFINDER 2 trial showed Galleri detected cancer 7x more often than standard screening alone — here’s what the evidence really means.
Full-Body MRI Screening: Is It Worth $2,500 to Know Everything?
95% of asymptomatic adults have at least one abnormal finding on whole-body MRI — but 91% are not clinically relevant. The evidence behind the $2,499 scan, and how to decide if it’s right for you.
Pharmacogenomics: Why the Same Medication Works Differently in Different People
Over 60% of adults have non-normal metabolism for common medications. Three genes drive 75% of preventable drug reactions. Why your dose should be calibrated to your genome — not your weight.
Tendon and Ligament Injuries: Why They Don’t Heal Well (and What Regenerative Medicine Can Do About It)
Avascular tissue, Type III scar collagen, and the chronic-degeneration problem. The biology behind why tendons don’t heal — and where PRP, ESWT, and proper loading actually move the needle.
The Truth About Exosome Therapy: What’s Real, What’s Marketing, and What the FDA Says
Zero FDA-approved exosome products. Warning letters escalating. The 351 vs. 361 distinction every patient should understand before paying thousands for an unapproved injection.
Shockwave Therapy + PRP: Why Combination Protocols Outperform Single Treatments
71% with PRP alone. 92.6% with PRP plus shockwave — and five weeks faster. The mechanotransduction biology behind why combination protocols beat single treatments for chronic tendon pain.
Regenerative Medicine for Spine Pain: Can Intradiscal PRP and BMAC Help You Avoid Spinal Fusion?
Before you consent to fusion, your biology deserves a seat at the table. The Pettine BMAC data, the cellular potency threshold, and how Pravida decides who’s actually a candidate.
BMAC for Knee Arthritis: What 10 Years of Evidence Actually Shows
20% TKA rate at 15 years with subchondral BMAC vs. 42% with intra-articular. The MILES trial in honest detail, the cell-count threshold, and who’s actually a candidate.
The Microbiome-Longevity Connection: What Your Gut Is Telling You About How You’ll Age
Centenarians share one trait that almost no doctor measures: a youthful gut microbiome. The evidence on inflammaging, the gut-brain axis, and what to do about it.
Hormone Optimization for Women: Beyond “It’s Just Perimenopause”
Perimenopause drives measurable changes in bone density, cardiovascular risk, and cognition. The 2024–2026 evidence on HRT timing, transdermal estradiol, micronized progesterone, and the testosterone gap.
Hormone Optimization for Men Over 40: What the Evidence Actually Supports
Testosterone declines 1–2% per year after 40 — free testosterone faster. The TRAVERSE trial, SHBG, DHEA-S, and what to actually measure beyond a single total testosterone number.
Fasting Insulin: The Most Important Blood Test You’ve Never Had
Fasting insulin and HOMA-IR detect insulin resistance 10–15 years before fasting glucose or A1c rise. Why standard panels skip this $35 test — and what your result actually means.
ApoB, Lp(a), and the Lipid Panel Your Cardiologist Should Be Ordering
ApoB outperforms LDL-C in 9 of 9 cardiovascular risk studies. Lp(a) affects 64 million Americans. The 2026 ACC/AHA guidelines now formally endorse both tests.
Biological Age vs. Chronological Age: How to Measure How Fast You're Actually Aging
GrimAge and DunedinPACE epigenetic clocks predict mortality more accurately than any standard lab test. Here’s what the 2024–2026 research shows about measuring and modifying your biological age.
CGM for Non-Diabetics: What a Month of Continuous Glucose Monitor Data Reveals
Your fasting glucose is normal. Your A1c is excellent. But CGM data reveals glycemic patterns that standard labs completely miss — and what they mean for longevity.
DEXA Scan Body Composition: Why Your Scale Is Lying to You
Your BMI can't see visceral fat or muscle loss. DEXA reveals the metabolic truth your weight hides — and why it's the body composition standard that matters.
The Science Behind CartiNova: How Fractional Laser Meets Regenerative Biology
An in-depth look at the innovative combination of Regenelease laser technology and biologics that makes non-surgical cartilage restoration possible.
Your Genome Is a Roadmap: How Genomics-Guided Medicine Changes Everything
Understanding how whole genome sequencing and AI analysis can predict health risks decades before symptoms appear.
VO2 Max Testing: Why This Single Number May Be the Best Predictor of How Long You'll Live
The largest study ever on fitness and mortality found low VO2 max is a stronger predictor of death than smoking, diabetes, or heart disease.
What Your Blood Work Isn't Telling You: Why Standard Lab Panels Miss 80% of the Picture
Your annual physical checks 20 markers. Comprehensive testing checks hundreds. Here's what the gap means for your health — and why it matters.
The 12 Hallmarks of Aging: What They Mean for Your Health Strategy
A comprehensive guide to the biological mechanisms of aging and how our Signature membership addresses each one.
PRP vs. Surgery for Joint Pain: What the Evidence Actually Says
A physician-level review of platelet-rich plasma evidence versus surgical intervention — what works, for whom, and when regenerative medicine is the right call.
More articles coming soon. Subscribe to our newsletter to be notified of new publications.